Lexaria Bioscience Corp Receives First Notice of Allowance for One of Several US Patent Applications from US Patent and Trademark Office - Video News Alert on Investmentpitch.com

July 13, 2016 3:09 PM EDT | Source: InvestmentPitch Media

Vancouver, British Columbia--(Newsfile Corp. - July 13, 2016) - Lexaria Bioscience Corp (CSE: LXX) (OTCQB: LXRP) has received its first Notice of Allowance for one of its US patent applications from the US Patent and Trademark Office. Management calls this a "watershed event" in its advancement as a bioscience company.

InvestmentPitch.com has produced a "video news alert" which discusses this news. If this link is not enabled, please visit www.InvestmentPitch.com and enter "Lexaria" in the search box. It is also available on YouTube (click here).



Cannot view this video? Visit:
http://www.investmentpitch.com/video/0_c5rl9awc/Lexaria-Bioscience-CSE-LXX-OTCQB-LXRP-received-its-first-notice-of-Allowance

Lexaria Bioscience, a food sciences company, is focused on the delivery of active compounds that can behave as superfoods through its proprietary infusion technologies.

In simple terms, by combining a lipophilic active agent and a taste enhancing oil with the food product, the company's unique technology allows for more efficient and effective absorption of molecules, while simultaneously masking, and at times even eliminating, inherent strong flavours and odors. The process is fully explained in a recent interview of Chris Bunka by Tia Borden, which is also available for viewing on www.InvestmentPitch.com.

The company plans to leverage its IP prowess for various areas of the economy, such as the rapidly evolving cannabinoid sector; the vitamin sector; the NSAID sector; and even the nicotine sector. The technology is extremely cost effective to implement and is applicable to the widest imaginable spectrum of foods. The company has a number of additional patent applications currently undergoing review by the US Patent and Trademark Office.

The company uses the technology in its own line of products, such as the ViPova™ CBD-infused hot beverages and Lexaria Energy CBD-infused protein energy bars.

John Docherty, President, stated: "Lexaria believes that anytime and every time it is successful in progressing a patent application into a granted patent, it not only reinforces the validity of its underlying encapsulation technology, but it also opens new areas of potential revenue generation and economic activity. Lexaria's allowed and pending patent portfolio is both broad and deep and its executives continue to investigate additional new areas of IP that could be symbiotic with that which is already known."

The company intends to complete a non-brokered private placement of up to US$300,000 through the issuance of up to 5 million units at US$0.06 per unit. Each unit consists of one share and one warrant, with each warrant is exercisable at US$0.14 for a period of two years.

For more information, please visit the company's website www.LexariaEnergy.com, or contact Chris Bunka, Chairman & CEO, at 250-765-6424 or email bossbunka@gmail.com.

About InvestmentPitch Media

InvestmentPitch Media is arguably the largest producer and distributer of video news content, primarily for small and mid-cap companies. The company specializes in producing short videos based on significant news releases, research reports and other content of interest to investors.

CONTACT:
InvestmentPitch Media
Barry Morgan, CFO
bmorgan@investmentpitch.com

info